80 mg tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly GLP-2 Tirzepatide (40mg vials) -

These findings position retatrutide as a leading investigational peptide for obesity, type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), and related metabolic disorders

7 Therapeutic strategies for DM-associated pulmonary injury The escalating global prevalence of DM necessitates future advancements in novel biomarker discovery and personalized therapeutic strategies

International Journal of Molecular Sciences, 22 (18)

Patients who consumed two or more alcoholic drinks per week within 12 hours of peptide dosing reported 40% lower subjective recovery improvements and 30% smaller reductions in body fat percentage over 90 days compared to abstinent users

singlecare.com 6VCU Health (2026)